Yellow Fever Vaccination Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
A Phase I Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers
Condition: Yellow FeverInterventions: Biological: YF Vax 17D Strain; Drug: ISA-720; Biological: MVA-BN Yellow Fever Vaccine; Other: Placebo; Biological: MVA Smallpox VaccineSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2016 Category: Research Source Type: clinical trials